Boston, MA – May 11, 2020 – Lumeon, the leader in care delivery automation, today announced that it has appointed Ray Wolski as Chief Revenue Officer. Mr. Wolski’s appointment comes as the company sees a surge in demand for the orchestration and automation of care delivery models.

Mr. Wolski will lead Lumeon’s business development strategy and execution in North America, building on his extensive experience in cultivating strong relationships with healthcare organizations and helping clients improve healthcare outcomes.

“Ray is an accomplished leader whose expertise will be instrumental in driving our U.S. expansion, as we continue to execute on our vision to help healthcare systems develop and scale new models of delivery that improve the quality of care whilst eliminating variation in care,” said Robbie Hughes, CEO, Lumeon. “He brings significant experience overseeing the revenue framework for complex, world-class healthcare organizations that will enable him to hit the ground running and ensure that we remain focused on maintaining our rapid growth rate.”

Mr. Wolski brings more than 30 years of experience guiding companies with high-performance client-facing teams that deliver innovative enterprise technology solutions. Prior to joining Lumeon, Mr. Wolski served as vice president of strategic solutions – U.S., Clinical Effectiveness, at Wolters Kluwer, where he was responsible for the growth of solutions including UpToDate. Mr. Wolski’s work with marketing, product development, customer success and operations resulted in unprecedented growth within Wolters Kluwer’s Clinical Effectiveness business unit.

“Clinical variation is a vexing problem in U.S. healthcare – it’s largely due to the knowledge gaps that exist among clinical staff and patients, which can lead to vast differences in medical procedures and outcomes,” said Wolski. “Lumeon’s care delivery automation platform has a proven track record in reducing variation by effectively guiding care teams to make the right decisions, while ensuring that these decisions are then executed reliably and consistently at enterprise scale. The company is steadily making its mark on the U.S. healthcare market, and I’m excited by the opportunity to contribute to its continued success.”